Tenecteplase versus alteplase for thrombolysis in patients selected by use of perfusion imaging within 4·5 h of onset of ischaemic stroke (TASTE): a multicentre, randomised, controlled, phase 3 non-inferiority trialMark Parsons, Andrew Bivard, Chon‐Haw Tsai et al.|The Lancet Neurology|2024Cited by 89